DSpace at VNU: Developing business strategies for Hau Giang Pharmaceutical Joint Stock Company (2012-2015)

Developing business strategies for Hau Giang
Pharmaceutical Joint Stock Company (20122015)
Nguyễn Quý Anh Tuấn
Khoa Quản trị Kinh doanh
Luận văn Thạc sĩ ngành: Kinh doanh và quản lý; Mã số:
Người hướng dẫn: TS. Vũ Anh Dũng
Năm bảo vệ: 2011
Keywords: Công ty cổ phần; Quản trị kinh doanh; Dược; Chiến lược kinh doanh
Content


TABLE OF CONTENTS
ACKNOWLEDGEMENTS.................................................................................i
ABSTRACT..........................................................................................................ii
TÓM TẮT.............................................................................................................v
TABLE OF CONTENTS .................................................................................viii
LIST OF TABLES..............................................................................................xi
LIST OF FIGURES...........................................................................................xii
LIST OF ABBREVIATIONS......................................................................... xiii
CHAPTER 1: INTRODUCTION ......................................................................1
1.1. Necessity of the thesis................................................................................1
1.2. Research aim and objectives....................................................................3
1.3. Research questions....................................................................................4
1.4. Research methodology..............................................................................4
1.5. Scope of the research ................................................................................5
1.6. Significance of the research......................................................................6
1.7. Suggestions for future research...............................................................7
1.8. Thesis structure.........................................................................................7
CHAPTER 2: LITERATURE REVIEW..........................................................9
2.1 Strategy overview.......................................................................................9
2.1.1 Strategy definition.......................................................................... 9

2.1.2 Hierarchy and types of strategy ................................................... 11
2.2 Strategic management process ...............................................................16
2.3

External

scanning:

macro

environment

and

industry

environment analysis...................................................................................17
2.3.1 Macro environmental analysis: P.E.S.T.E.L Model ..................... 17
2.3.2 Industry environment analysis ..................................................... 18

viii


2.3.3 Synthesis of external factors – External Factors Analysis Summary
(EFAS) ................................................................................................. 23
2.4 Internal scanning: organization analysis...............................................25
2.4.1 Resource-based view of the firm .................................................. 25
2.4.2 Value chain of the firm................................................................. 26
2.4.3 Synthesis of internal factors – Internal Factors Analysis Summary
(IFAS) ................................................................................................. 28

2.5 Strategy formulation................................................................................29
2.6 Strategy implementation.........................................................................30
2.6.1 Management issues...................................................................... 30
2.6.2 Tactical issues ............................................................................. 34
2.7 Strategy evaluation and control..............................................................35
2.8 Chapter review.........................................................................................37
CHAPTER

3:

ANALYSIS

ON

VIETNAM PHARMACEUTICAL

MARKET............................................................................................................39
3.1. Overview of Vietnam pharmaceutical market.....................................39
3.2. Notable characteristics of Vietnam pharmaceutical market..............42
3.3. Forecasts on Vietnam pharmaceutical market in 2012 – 2015 ..........50
3.3.1. Development prospects of Vietnam pharmaceutical market ........ 50
3.3.2. Prescription drug market forecast .............................................. 51
3.3.3. OTC drug market forecast .......................................................... 51
3.3.4. Patented Drug Market Forecast ................................................. 52
3.3.5. Generic drug market forecast ..................................................... 53
3.3.6. Pharmaceutical Trade forecast................................................... 54
3.4. Synthesis of External Factors – EFAS (External Factors Analysis
Summary) .......................................................................................................55
3.5. Chapter review........................................................................................58

ix


CHAPTER 4: ANALYSIS ON DHG PHARMACEUTICAL COMPANY62
4.1 Overview of DHG pharmaceutical company........................................62
4.1.1 Establishment and development of DHG...................................... 62
4.1.2 Scope of business and major products of DHG ............................ 64
4.1.3 Vision, mission and core values of DHG...................................... 65
4.1.4 Organizational structure of DHG ................................................ 66
4.1.5 Business performance of DHG..................................................... 67
4.3 Internal analysis for DHG.......................................................................69
4.3.1 Value chain analysis of DHG....................................................... 70
4.3.2 Distinctive competencies of DHG ................................................ 75
4.4 Competitive position of DHG .................................................................77
4.5 Synthesis of internal factors – IFAS (Internal Factors Analysis
Summary) ......................................................................................................87
4.6 Chapter review.........................................................................................91
CHAPTER 5: STRATEGY DEVELOPMENT FOR DHG IN 2012 – 2015 93
5.1 Orientations and objectives of DHG in 2012-2015 ...............................93
5.2 Strategy development for DHG..............................................................94
5.2.1 International experience on strategy development ....................... 94
5.2.2 TOWS Matrix of DHG ................................................................. 95
5.2.3 Strategy development of DHG in 2012 - 2015.............................. 97
5.3 Recommendations for implementing and controlling DHG’s
strategies........................................................................................................105
CONCLUSION ................................................................................................107
REFERENCES.................................................................................................109

x

REFERENCES
English:
1. David, F. (1986), “The Strategic Planning Matrix – A Quantitative
Approach”, Long Range Planning, Vol.19, No.5, p.102.
2. Barney, J. B. (1999), “Looking inside for competitive advantage”,
Academy of Management Executive, p.9.
3. Business

Monitor

International

(BMI)

(Q42010),

Vietnam

Pharmaceuticals and Healthcare Industry Report: Including 5-year and
10-year industry forecasts by BMI..
4. Byars, L.L., Rue L.W. and Zahza, S.A (1996), Strategic Management,
Irvin.
5. Hitt, M.A., Ireland, R and Hoskisson, R.E. (1999), Strategic Management:
Competition and Globalization, South-Western College Publishing.
6. Hunger and Wheelen (2000), Essentials of Strategic Management, Prentice Hall.
7. Kumar, R. (2005), Research Methodology: a step-by-step guide for beginners,
SAGE
8. Niven,

P.

(2002),

Balanced

scorecard

step-by-step:

maximizing

performance and maintaining results, John Wiley and Sons.
9. Porter, M.E. (1980), Competitive strategy: techniques for analyzing
industries and competitors, Free Press.
10.Radder, L. and Louw, L. (1998), “The SPACE Matrix: A Tool for
Calibrating Competition”, Long Range Planning, Vol.31, No.4, pp. 549.
11.Thompson, A.A. and Strickland, A.J. (1998), Strategic Management:
Concept and Cases, Irwin/McGraw-Hill.
12.Weihrich, H. (1982), “The TOWS Matrix – A Tool for Situational
Analysis”, Long-Range Planning, Volume 15, no.2, p.61.
13.“The success story of Sun Pharma”. 25/5/2007. Rediff India Abroad.
Retrieved from />
109


14.“M&A of Sun Pharma”. 30/12/2010. Retrieved from
/>Vietnamese:
1. “Thị trường dược phẩm tăng trưởng 25%” 31/5/2010. Báo điện tử Thời
báo Kinh tế Sài Gòn.

“Vietnam pharmaceutical market increases 25%”. 31/5/2010. SaigonTimes
Online. Retrieved from
/>2. “DHG đạt lợi nhuận gấp đôi cùng kỳ”. 1/12/2009. Báo điện tử Thời báo
Kinh tế Việt Nam.
“DHG’s profit: twice as high as that of the last year period”. 1/12/2009.
Vneconomy. Retrieved from
/>3. “Thị trường dược và chuyển động từ phía nhà đầu tư ngoại”. “30/11/2010.
Báo điện tử Thời báo Kinh tế Việt Nam.
Pharmaceutical market and moves of foreign investors”. 30/11/2010.
Vneconomy. Retrieved from
/>4. “SaViPharm cung ứng thuốc cho GlaxoSmithKline”. 16/12/2010. Báo điện
tử Thời báo Kinh tế Sài Gòn.
“SaViPharm manufactures medicine for GlaxoSmithKline”. 16/12/2010.
SaigonTimes Online. Retrieved from
/>arm-cung-ung-thuoc-cho-GlaxoSmithKline.html
5. “Sản xuất thuốc phải nhập khẩu 90% nguyên liệu ”. 27/7/2010. Báo điện
tử Thanh Niên.

110


“ Manufacturing medicine has to import 90% materials”. 27/7/2010.
ThanhNien Online. Retrieved from
/>6. “Hướng đi mới cho nguyên liệu dược”. 25/10/2010. Báo Điện tử Nhịp Cầu
Đầu tư
“New direction for pharmaceutical materials”. 25/10/2010. Nhip Cau Dau
Tu Online. Retrieved from
/>7. “Sản xuất nguyên liệu thuốc kháng sinh: Phập phù tìm đầu ra”. 13/8/2010.
Báo điện tử Sài Gòn Giải Phóng.
“Producing antibiotics materials: Difficult to find buyers”.

13/8/2010.SGGP Online. Retrieved from
/>8. “Quy hoạch về phát triển ngành công nghiệp hóa dược đến năm 2015 tầm
nhìn 2025”. Cổng thông tin điện tử Chính Phủ.
“Plans for the development of the pharmaceutical chemical industry till
2015 and vision until 2020 ”. Vietnam Government Online Portal.
Retrieved from
/>&_schema=PORTAL&docid=87182
9. “Công nghiệp Dược Việt Nam – Bước khởi đầu gian nan”. 27/2.2010. Báo
Điện tử Tuổi Trẻ.
“Vietnam pharmaceutical industry – Difficult start”. 27/2.2010. Tuoi tre
Online.
Retrieved from />10.Bảng cáo bạch công bố thông tin (nếu có) của các công ty dược DHG,
DVD, IMP, DMC, DBT, DCL, DHT, OPC, TRA.

111


Prospectuses (if any) of pharmaceutical companies DHG, DVD, IMP,
DMC, DBT, DCL, DHT, OPC, TRA.
11.Báo cáo thường niên 2006 - 2009 (nếu có) của các công ty dược DHG,
DVD, IMP, DMC, DBT, DCL, DHT, OPC, TRA.
Annual Reports 2006 – 2009 (if any) of pharmaceutical companies DHG,
DVD, IMP, DMC, DBT, DCL, DHT, OPC, TRA.
12.Báo cáo tài chính 2006 - 2009 (nếu có) của các công ty dược DHG, DVD,
IMP, DMC, DBT, DCL, DHT, OPC, TRA.
Financial Reports 2006 - 2009 (if any) of pharmaceutical companies DHG,
DVD, IMP, DMC, DBT, DCL, DHT, OPC, TRA.
Website
1. Ho Chi Minh Securities Exchange website, www.hose.vn
2. Hanoi Securities Exchange website, www.hnx.vn

3. DHG website, www.dhgpharma.com.vn
4. DVD website, www.viendongpharma.com.vn
5. IMP website, www.imexpharm.com.vn
6. DMC website, www.domesco.com.vn
7. DBT website, www.bentrepharma.com.vn
8. DCL website, www.cuulongpharma.com.vn
9. DHT website, www.hataypharma.com.vn
10.OPC website, www.opc.com.vn
11.TRA website, www.traphaco.com.vn
12. Sanofi-Aventis Vietnam website, www.sanofi-aventis.com.vn
13. Pfizer website, www.pfizer.com
14. Novatis website, www.novatis.com
15. MSD Vietnam website, www.msd-vietnam.com
16.GSK Vietnam Website, www.gsk.com/worldwide/vn.htm

112